N038094 N0 Ruling Active

The tariff classification of Nomegesterol Acetate (CAS-58652-20-3) and Venlafaxine Hydrochloride (CAS-99300-78-4) in bulk form, from Italy and China, respectively

Issued September 19, 2008 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 2922.50.2500, 2937.23.5050

Headings: 2937, 2922

Product description

The first product, Nomegesterol Acetate, is a progestin, which is a synthetic hormone. It is commonly used as an oral contraceptive. The second product, Venlafaxine Hydrochloride, is an antidepressant drug. It is indicated for the treatment of depression and anxiety disorders.

CBP rationale

The applicable subheading for the Nomegesterol Acetate in bulk form will be 2937.23.5050, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Steroidal hormones, their derivatives and structural analogues: Estrogens and progestins: Other: Other: Other: Other. The applicable subheading for the Venlafaxine Hydrochloride in bulk form will be 2922.50.2500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Oxygen-function amino-compounds: Amino-alcohol-phenols, amino-acid-phenols and other amino compounds with oxygen function: Aromatic: Other: Drugs: Other: Other.

Full text

N038094 September 19, 2008 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2937.23.5050; 2922.50.2500 Ms. Inge Forstenzer Ren-Pharm International, Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Nomegesterol Acetate (CAS-58652-20-3) and Venlafaxine Hydrochloride (CAS-99300-78-4) in bulk form, from Italy and China, respectively Dear Ms. Forstenzer: In your letter dated September 2, 2008, you requested a tariff classification ruling. The first product, Nomegesterol Acetate, is a progestin, which is a synthetic hormone. It is commonly used as an oral contraceptive. The second product, Venlafaxine Hydrochloride, is an antidepressant drug. It is indicated for the treatment of depression and anxiety disorders. The applicable subheading for the Nomegesterol Acetate in bulk form will be 2937.23.5050, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Steroidal hormones, their derivatives and structural analogues: Estrogens and progestins: Other: Other: Other: Other.” The rate of duty will be free. The applicable subheading for the Venlafaxine Hydrochloride in bulk form will be 2922.50.2500, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Oxygen-function amino-compounds: Amino-alcohol-phenols, amino-acid-phenols and other amino compounds with oxygen function: Aromatic: Other: Drugs: Other: Other.” Pursuant to General Note 13, HTS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →